Bionic Sight, Inc.
PrivateLast Round
VC Round
Apr 1, 2025
Est. Valuation
$40M
Company Overview
Bionic Sight, Inc. operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a VC Round in April 2025.
Bionic Sight, Inc. is a biotechnology company developing optogenetic gene therapies and neuro-prosthetic devices to restore sight to patients with retinal degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B2C
Customer Profile
Revenue Share, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionic Sight, Inc. Comparables
Compare Bionic Sight, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ray Therapeutics | 88% | |
| Nanoscope Therapeutics Inc. | 86% | |
| SparingVision | 83% |
For institutional investors. Book with your work email.
Bionic Sight, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 1, 2025 | ||||
| VC Round | Jan 24, 2017 |
For institutional investors. Book with your work email.
Bionic Sight, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Raptor Group | VC Round |
| Partnership for New York City | VC Round |
| Cornell University Office of University Investments | VC Round |
| Samsara BioCapital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
Raised capital from Partnership Fund for New York City.
- Jan 24, 2017
$2M round led by Beacon Therapeutics.
For institutional investors. Book with your work email.
Bionic Sight, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bionic Sight, Inc.'s valuation, stock price, and market status.
Is Bionic Sight, Inc. a public or private company?
Bionic Sight, Inc. is a private company.
What is the current stock price of Bionic Sight, Inc.?
Bionic Sight, Inc. is a private company, so its shares have no public market price. Caplight tracks Bionic Sight, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bionic Sight, Inc. worth (valuation)?
Bionic Sight, Inc.'s valuation is estimated at $40.0M based on funding round data.
Can I buy Bionic Sight, Inc. stock?
Bionic Sight, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bionic Sight, Inc.'s last funding round?
Bionic Sight, Inc.'s most recent funding round was VC Round on April 1, 2025.
Who are the main investors in Bionic Sight, Inc.?
Key investors in Bionic Sight, Inc. include The Raptor Group, Partnership for New York City, Cornell University Office of University Investments, Samsara BioCapital.
Will Bionic Sight, Inc. IPO soon?
No public IPO plans have been announced for Bionic Sight, Inc..
How can I track Bionic Sight, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Bionic Sight, Inc.'s shares on secondary markets.